Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid plus epinephrine versus epinephrine alone for bleeding control in external dacryocystorhinostomy
PACTR202206674510595Recruiting
- Sponsor
- Zagazig University
- Start
- May 2022
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label trial of tranexamic acid and epinephrine in Primary acquired nasolacrimal duct obstruction (PANDO) (2 arms), sponsored by Zagazig University. Primary endpoint: Amount of intraoperative bleeding. Started May 2022; status: recruiting.
02
Drugs
tranexamic acidepinephrine
03
Conditions
Primary acquired nasolacrimal duct obstruction (PANDO)
Beyond the preview
Go deeper on PACTR202206674510595.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202206674510595.